Characterization of SPf(66)n: a chimeric molecule used as a malaria vaccine
- 31 December 1994
- Vol. 12 (7) , 585-591
- https://doi.org/10.1016/0264-410x(94)90261-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and designVaccine, 1994
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityVaccine, 1992
- Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1–14 yearsVaccine, 1992
- Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66Parasite Immunology, 1992
- Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparumParasite Immunology, 1991
- Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malariaClinical and Experimental Immunology, 1991
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Induction of protective immunity against experimental infection with malaria using synthetic peptidesNature, 1987
- Direct microsequence analysis of polypeptides using an improved sequenator, a nonprotein carrier (Polybrene), and high pressure liquid chromatographyBiochemistry, 1978